Skip to main content

Opinion: To reduce seniors' drug costs, expand Medicare Advantage

By National Review  
   December 03, 2018

As prescription-drug costs have risen steadily in recent years, politicians of both parties have made audacious claims that billions could be saved by imposing lower prices on drugmakers. Yet newly developed drugs are expensive because they are enormously valuable to patients relative to existing alternative treatments.

Full story


Get the latest on healthcare leadership in your inbox.